You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BCAX Sale Disclosure
Hyep Ivan · SEC Form 4 · Filed Jul 10, 2026
Sale
Calculated transaction value
$25.16K
Hyep Ivan Chief Financial Officer
BCAX
Transaction date
Jul 8, 2026
Public filing date
Jul 10, 2026
Filing lag
Filed 2 days later
BCAX daily price context
Close on/before transaction
$28.99
Jul 8, 2026
First close after public filing
$28.15
Jul 13, 2026
30-day return after filing
-1.49%
Through Aug 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 830 shares @ $30.31
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001470831-26-000700
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$855.04K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bicara Therapeutics Inc. BCAX | Exercise | Jul 8, 2026 | $47.37K |
| Bicara Therapeutics Inc. BCAX | Sale | Jul 8, 2026 | $650.9K |
| Bicara Therapeutics Inc. BCAX | Sale | Jul 8, 2026 | $131.62K |
| Bicara Therapeutics Inc. BCAX Current | Sale | Jul 8, 2026 | $25.16K |
| Bicara Therapeutics Inc. BCAX | Exercise | Jul 8, 2026 | $0 |
| Bicara Therapeutics Inc. BCAX | Exercise | Jul 8, 2026 | $0 |